US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

42.61

+0.93212.24%

Post-market: 42.680.0729+0.17%16:10 EDT

Volume:561

Turnover:23.88K

Market Cap:118.32M

PE:- -

High:42.68

Open:42.52

Low:42.52

Close:41.68

52wk High:48.78

52wk Low:29.44

Shares:2.78M

Float Shares:2.78M

Volume Ratio:0.36

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Spyre Therapeutics Grants Inducement Awards of 2,106 Stock Options, 745 RSUs to New Employee

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics CEO Turtle Cameron Disposes of 15,000 Common Shares Worth $1.31 Million

LivaNova Presents at Morgan Stanley Global Healthcare Conference

LivaNova Files Form 3 for Chief Legal Officer Anne M. Liddy

LivaNova Director Francesco Bianchi Sells 1,650 Shares for $131,538

Cogent Biosciences - to Purchase Minimum Percentages of Bezuclastinib Products from Hovione - SEC Filing

THOMSON REUTERS

Cogent Biosciences - Agreement Effective for Five-Year Term with Automatic Two-Year Renewals - SEC Filing

THOMSON REUTERS

Cogent Biosciences - Enters Commercial Supply Agreement with Hovione on Sept 1, 2026 - SEC Filing

THOMSON REUTERS

Cogent Biosciences Signs Hovione Supply Deal for Bezuclastinib Tablets

LivaNova Price Target Raised to $90.00/Share from $87.00 by Piper Sandler

uniQure seeks accelerated approval for Huntington’s gene therapy

LivaNova price target raised to $90 from $87 at Piper Sandler

Guardant Health Price Target Maintained with a $195.00/Share by BTIG

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)

Guardant Health Shield Blood Test Wins Carelon Coverage for Colorectal Cancer Screening

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Cogent Biosciences Director Arlene Morris Disposes of USD 1.69 Million in Common Shares

Circio boosts circVec gene therapy data and secures funding runway to 2030

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LFSC/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":42.6071,"timestamp":1791576000000,"preClose":41.675,"halted":0,"volume":561,"hourTrading":{"tag":"盘后","latestPrice":42.68,"preClose":42.6071,"latestTime":"16:10 EDT","volume":1,"amount":42.6071,"timestamp":1791576604081,"change":0.0729,"changeRate":0.001711,"amplitude":0},"delay":0,"changeRate":0.022365926814637206,"floatShares":2777035,"shares":2777035,"eps":0,"marketStatus":"Market Closed","change":0.9321,"latestTime":"10-09 16:00:00 EDT","open":42.515,"high":42.68,"low":42.515,"amount":23883,"amplitude":0.003959,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":41.675,"sharesOutstanding":2657035,"nav":41.68,"aum":115746818.8,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":42.68,"preClose":42.6071,"latestTime":"16:10 EDT","volume":1,"amount":42.6071,"timestamp":1791576604081,"change":0.0729,"changeRate":0.001711,"amplitude":0},"volumeRatio":0.35855808645794174},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2777035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.35855808645794174,"shares":2777035,"dividePrice":0,"high":42.68,"amplitude":0.003959,"preClose":41.675,"low":42.515,"week52Low":29.4441,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":42.6071,"eps":0,"divideRate":0,"volume":561,"delay":0,"ttmEps":0,"open":42.515,"prevYearClose":36.6147,"prevWeekClose":43.401,"prevMonthClose":44.5697,"prevQuarterClose":44.5697,"fiveDayClose":43.401,"twentyDayClose":45.3275,"sixtyDayClose":44.9054},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665359486","title":"Spyre Therapeutics Grants Inducement Awards of 2,106 Stock Options, 745 RSUs to New Employee","url":"https://stock-news.laohu8.com/highlight/detail?id=2665359486","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665359486?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:01","pubTimestamp":1788552087,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics grants inducement awards of 2,106 stock options, 745 RSUs to new employeeSpyre Therapeutics granted inducement equity awards to one non-executive employee under its 2018 Equity Indu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL2lPXJr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","IE00BKPKM429.USD","LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD","LFSC","SG9999014005.SGD","BK4585","BK4588","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014021.USD","NDAQ","LU2095319765.USD","IE00BN0W2W23.USD","BCDF","SYRE","BK4139","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","BK4112","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351482","title":"Spyre Therapeutics Announces Grants of Inducement Awards","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351482","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351482?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:01","pubTimestamp":1788552060,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Sept.  04, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company committed to developing next-generation t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/04/3356774/0/en/spyre-therapeutics-announces-grants-of-inducement-awards.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139","LENZ","BK4539","LFSC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388298","title":"Spyre Therapeutics CEO Turtle Cameron Disposes of 15,000 Common Shares Worth $1.31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388298","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388298?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:33","pubTimestamp":1788485613,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics CEO Turtle Cameron disposes of 15,000 common shares worth $1.31 millionSpyre Therapeutics CEO Turtle Cameron sold 15,000 common shares on Sep. 1, 2026 at weighted-average prices of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL63hWDH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Spyre Therapeutics CEO Turtle Cameron Disposes of 15,000 Common Shares Worth $1.31 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664687247","title":"LivaNova Presents at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664687247","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664687247?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:02","pubTimestamp":1788440554,"startTime":"0","endTime":"0","summary":"LivaNova presents at Morgan Stanley Global Healthcare ConferenceLivaNova will present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York on Sept. 14.The company will also prese","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL1k8m7D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","LU0225283273.USD","LU0106831901.USD","LU2089284900.SGD","BK4588","KBWB","LU0390134368.USD","LU2065171402.SGD","LU1720051108.HKD","LU1668664300.SGD","LIVN","LU1791710400.SGD","LU2271345857.HKD","LU2065170008.USD","LU0795875169.SGD","LU0006306889.USD","LU1720051017.SGD","LU1244550494.USD","LU0053666078.USD","LU0158827781.USD","IE00BZ1G4Q59.USD","LU1074936037.SGD","LU0234570918.USD","LU0882574139.USD","LU0557290698.USD","LU0314104364.USD","LU1363072403.SGD","LU1548497426.USD","LU2264538146.SGD","LU0912757837.SGD","BK4581","LU0210528500.USD","LU2111349929.HKD","LU0320765646.SGD","LFSC","LU1064131342.USD","LU2065169927.USD","LU1988902786.USD","BK4082","LU0795875086.SGD","LU2028103732.USD","LU1791710582.SGD","LU1732800096.USD","LU2133065610.SGD","LU0158827948.USD","LU2023251221.USD","LU2089283258.USD","IAI","LU1244550221.USD","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849214","title":"LivaNova Files Form 3 for Chief Legal Officer Anne M. Liddy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849214","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849214?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:20","pubTimestamp":1788380419,"startTime":"0","endTime":"0","summary":"LivaNova files Form 3 for Chief Legal Officer Anne M. LiddyLivaNova filed an initial Form 3 for Chief Legal Officer Anne M. Liddy, dated Aug. 31, 2026.Disclaimer:This news brief was created by Public ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL4FZGNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIVN","LU2065169927.USD","BK4082","LU2065171402.SGD","LU2065171311.SGD","LU2065170008.USD","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664984921","title":"LivaNova Director Francesco Bianchi Sells 1,650 Shares for $131,538","url":"https://stock-news.laohu8.com/highlight/detail?id=2664984921","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664984921?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:20","pubTimestamp":1788380413,"startTime":"0","endTime":"0","summary":"LivaNova director Francesco Bianchi sells 1,650 shares for $131,538Director Francesco Bianchi sold 1,650 ordinary shares on Aug. 31, 2026 at $79.72.Direct holdings fell to 7,934 ordinary shares follow","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLsNS2b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LivaNova Director Francesco Bianchi Sells 1,650 Shares for $131,538","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","LFSC","LU2065171402.SGD","LU2065169927.USD","LU2065171311.SGD","BK4082","LIVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849672","title":"Cogent Biosciences - to Purchase Minimum Percentages of Bezuclastinib Products from Hovione - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849672","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849672?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:12","pubTimestamp":1788379965,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U1B9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LFSC","BK4505","CANC","COGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849670","title":"Cogent Biosciences - Agreement Effective for Five-Year Term with Automatic Two-Year Renewals - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849670","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849670?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:12","pubTimestamp":1788379965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U1B9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","COGT","BK4505","BK4139","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664496778","title":"Cogent Biosciences - Enters Commercial Supply Agreement with Hovione on Sept 1, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664496778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664496778?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:12","pubTimestamp":1788379965,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U1B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","COGT","CANC","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664981849","title":"Cogent Biosciences Signs Hovione Supply Deal for Bezuclastinib Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664981849","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664981849?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:12","pubTimestamp":1788379947,"startTime":"0","endTime":"0","summary":"Cogent Biosciences signs Hovione supply deal for bezuclastinib tabletsCogent Biosciences signed a commercial supply agreement with Hovione on Sept. 1, 2026, covering bezuclastinib spray-dried dispersi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL1zKvxT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","CANC","LFSC","COGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664584350","title":"LivaNova Price Target Raised to $90.00/Share from $87.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2664584350","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664584350?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:42","pubTimestamp":1788367320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LIVN/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","LFSC","LU2065171402.SGD","LU2065169927.USD","LU2065171311.SGD","BK4082","LIVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819175","title":"uniQure seeks accelerated approval for Huntington’s gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819175?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350375,"startTime":"0","endTime":"0","summary":"The latest update is out from uniQure ( ($QURE) ). On September 2, 2026, uniQure submitted a Biologics License Application to the U.S. Food and Dru...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","IBBQ","GNOM","CNCR","LFSC","TBXU","BK4585","BK4588","IBB","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881517","title":"LivaNova price target raised to $90 from $87 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881517?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:45","pubTimestamp":1788345909,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on LivaNova (LIVN) to $90 from $87 and keeps an Overweight rating on the shares. Following concerns ov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/livanova-price-target-raised-to-90-from-87-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/livanova-price-target-raised-to-90-from-87-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","LIVN","LU2065171311.SGD","LFSC","LU2065169927.USD","LU2065171402.SGD","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818611","title":"Guardant Health Price Target Maintained with a $195.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818611","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818611?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:52","pubTimestamp":1788342720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4585","BK4551","BK4196","LU0889565916.HKD","BK4588","GH","LU0320765992.SGD","GNOM","BK4535","EKG","FFOX","HELX","PTH","LFSC","GDOC","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863257","title":"Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863257","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664863257?lang=en_us&edition=fundamental","pubTime":"2026-09-02 01:40","pubTimestamp":1788284405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Guardant Health (GH) with bullis...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-medtronic-mdt-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-medtronic-mdt-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","XBI","LU1983299246.USD","LU0072461881.USD","LU2089284900.SGD","BK4535","LU1571399168.USD","LFSC","LU0128526141.USD","LU0976567544.SGD","LU0158827781.USD","LU1061106388.HKD","LU1244550221.USD","PTH","LU0106261372.USD","LU1506573853.SGD","HELX","LU0211331839.USD","IE00BFXG1179.USD","LU0029874061.USD","IE000M9KFDE8.USD","LU0265550946.USD","LU1291159041.SGD","LU1989764748.USD","EKG","BK4082","LU2023251221.USD","LU2271345857.HKD","IE00BQXX3C00.GBP","GNMX","LU2028103732.USD","GH","IE00BQXX3F31.USD","FFOX","LU0211326755.USD","LU2089283258.USD","LU0109394709.USD","LU0208291251.USD","LU0889565916.HKD","HCSG","IE00B3PB1722.GBP","XLV","LABU","LU0320765489.SGD","LU1989771016.USD","GNOM","MDT","LU1116320737.USD","LU0162691827.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856780","title":"Guardant Health Shield Blood Test Wins Carelon Coverage for Colorectal Cancer Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856780","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856780?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:06","pubTimestamp":1788264367,"startTime":"0","endTime":"0","summary":"Guardant Health Shield blood test wins Carelon coverage for colorectal cancer screeningGuardant Health secured Carelon Healthcare Services coverage for its FDA-approved Shield blood test for colorecta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL9hPZ6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LFSC","GNMX","BK4535","GH","BK4196","GDOC","BK4585","EKG","FFOX","GNOM","PTH","BK4588","BK4551","LU0320765992.SGD","LU0109394709.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856297","title":"Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856297?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"BRIDGEWATER N.J., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354079/0/en/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","LU0029874061.USD","BK4588","BK4581","GNOM","CNCR","BK4139","LFSC","LABU","LEGN","CANC","BK4585","HCSG","TBXU","BK4505","SYNB","IBB","LU0128526141.USD","MEDI","XLV","MEMS","FBT","IBBQ","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","IDNA","IE00B2B36J28.USD","BK4007","LFSC","IE00BFTCPJ56.SGD","FBT","LU0211331839.USD","IE00BJT1NW94.SGD","SYNB","IE0009355771.USD","CNCR","IBBQ","LU0070302665.USD","NVS","PPH","BMED","LU0208291251.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4585","BK4588","HYLG","BK4578","BK4532","IE0002141913.USD","LU0320765489.SGD","GNOM","IBB","NVIB","TBXU","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664788376","title":"Cogent Biosciences Director Arlene Morris Disposes of USD 1.69 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664788376","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664788376?lang=en_us&edition=fundamental","pubTime":"2026-09-01 05:02","pubTimestamp":1788210166,"startTime":"0","endTime":"0","summary":"Cogent Biosciences director Arlene Morris disposes of USD 1.69 million in common sharesCogent Biosciences director Arlene Morris sold 45,510 common shares on Aug. 27 under a Rule 10b5-1 plan.Disposals","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLbkSwZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cogent Biosciences Director Arlene Morris Disposes of USD 1.69 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COGT","CANC","BK4139","BK4505","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000711","title":"Circio boosts circVec gene therapy data and secures funding runway to 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000711?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:03","pubTimestamp":1788203022,"startTime":"0","endTime":"0","summary":"The latest update is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA reported that new preclinical data show its circVec circular RNA tech...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","GNOM","IBB","IE0009354923.USD","SYNB","TBXU","BK4505","BK4139","BK4585","BK4588","LFSC","FBT","RNA","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}